ALPHA TRIBE

Sai Life Sciences LimitedUpdates, 06-08-2026: Press Release

06-08-2026 | 11:23 pm

Sai Life Sciences reported a strong Q1FY27: Revenue ₹554 Cr (+12% YoY), PAT ₹73 Cr (+22% YoY). CRO business grew 24%. A new 100,000 sq. ft. R&D facility operationalized. Strategic pharma engagements and strong CMC pipeline drive multi-year growth outlook.

No comments yet. Be the first to comment!

All announcements from Sai Life Sciences Limited